Royal Bank of Canada raised its target price and gave an outperform rating for Globus Medical. Needham & Company also increased its target price and gave a buy rating.
2 reports, 1 independent
Updated Aug 3
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Royal Bank of Canada raised its target price and gave an outperform rating for Globus Medical. Needham & Company also increased its target price and gave a buy rating.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Globus Medical
company
-
Royal Bank of Canada
financial institution in Canada
-
Needham & Company
American independent investment bank and asset management firm
Related events
- Royal Bank of Canada, Citigroup, and Morgan Stanley issued price target and rating updates on August 27, 2026.
- Financial firms including Royal Bank of Canada, Truist Financial, TD Cowen, and Barclays have announced price target increases for Medpace.
- Analyst raised price target and gave outperform rating for Aramark on August 19, 2026.
- Royal Bank of Canada provided a price target and reaffirmed a sector perform rating for Plains All American Pipeline.
- RBC and Truist Financial issued rating updates and price targets for LINE.